Jeffrey Duchemin is CEO at HARVARD BIOSCIENCE INC (HBIO). They have made 10 open-market trades across 1 company since 2015, most recently 2019-07-07.
CIK 0001585223
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
4 open-market purchases totalling $200K since 2015, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| HBIO | 464,528 | $3.8M |
Shares reported on the most recent Form 4, priced at the 2019-07-09 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| HBIO | SELL | 2019-04-11 | 2019-04-12 | $4.51 | $56K | -15.5% | -49.9% | -59.7% |
| HBIO | SELL | 2019-04-10 | 2019-04-12 | $4.51 | $86K | -15.5% | -49.9% | -59.7% |
| HBIO | SELL | 2018-08-07 | 2018-08-09 | $6.18 | $927K | -6.8% | -15.0% | -37.4% |
| HBIO | SELL | 2018-07-09 | 2018-07-11 | $5.33 | $364K | -3.3% | +21.7% | -13.2% |
| HBIO | SELL | 2018-03-08 | 2018-03-12 | $4.52 | $752K | +1.0% | +16.5% | +8.2% |
| HBIO | SELL | 2017-06-12 | 2017-06-13 | $2.66 | $59K | +2.9% | -6.7% | +23.8% |
| HBIO | BUY | 2017-06-12 | 2017-06-13 | $2.76 | $121K | +2.9% | -6.7% | +23.8% |
| HBIO | BUY | 2016-11-03 | 2016-11-03 | $2.42 | $36K | +15.6% | +6.7% | +42.2% |
| HBIO | BUY | 2015-12-10 | 2015-12-11 | $3.37 | $34K | -21.7% | -15.7% | -18.0% |
| HBIO | BUY | 2015-09-02 | 2015-09-02 | $4.41 | $9K | -21.7% | -6.4% | -6.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.